select a format

Single User License
USD 250 INR 16073
Site License
USD 500 INR 32145
Corporate User License
USD 750 INR 48218

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


AveXis Inc (AVXS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

AveXis Inc (AVXS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH513303D
  • |
  • Pages: 33
  • |
  • July 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

AveXis Inc (AveXis), formerly BioLife Cell Bank Inc is a drug development company that develops innovative treatments for rare and potentially fatal neurological genetic diseases. The company offers AVXS-101, a proprietary gene therapy candidate used for the treatment of spinal muscular atrophy. Its AVXS-101 was granted orphan drug designation by the FDA and EMA for the treatment of all types of spinal muscular atrophy. The company develops gene therapies for SMA Type 1 and for other SMA sub-categories. It partners with academic institutes and research centers for product development. AveXis is headquartered in Bannockburn, Illinois, the US.

AveXis Inc (AVXS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AveXis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AveXis Inc, Medical Devices Deals, 2011 to YTD 2017 9

AveXis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

AveXis Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

AveXis Raises USD65 Million in Venture Financing 11

AveXis Raises USD10 Million in Series C Financing Round 12

Licensing Agreements 13

AveXis Enters into Licensing Agreement with Regenxbio 13

AveXis Amends Licensing Agreement with Nationwide Children's Hospital 15

Asklepios BioPharma Enters into Licensing Agreement with AveXis 15

ReGenX Biosciences Enters Into Licensing Agreement With AveXis 16

Equity Offering 17

AveXis Raises USD287.8 Million in Public Offering of Shares 17

AveXis Prices Public Offering of Shares for USD146.6 Million 19

AveXis Completes Underwriter's Exercise of Over-Allotment Option of IPO 20

AveXis Raises USD2 Million in Private Placement of Shares and Warrants 21

Debt Offering 22

AveXis Raises USD0.5 Million in Private Placement of 8% Notes 22

AveXis Inc-Key Competitors 23

Key Employees 24

Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Financial Announcements 26

Nov 10, 2016: AveXis Reports Third Quarter 2016 Financial and Operating Results 26

Aug 11, 2016: AveXis Reports Second Quarter 2016 Financial and Operating Results 28

Mar 16, 2016: AveXis Reports Fourth Quarter and Full Year 2015 Financial and Operating Results 29

Corporate Communications 31

Feb 15, 2017: AveXis Appoints Rick Modi as Senior Vice President and Chief Business Officer 31

Mar 07, 2016: AveXis Announces Appointments of Daniel G. Welch, Terrence C. Kearney and Frank Verwiel, M.D. to Board of Directors 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

AveXis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AveXis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

AveXis Inc, Medical Devices Deals, 2011 to YTD 2017 9

List of Tables

AveXis Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 1

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

AveXis Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

AveXis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

AveXis Inc, Deals By Therapy Area, 2011 to YTD 2017 8

AveXis Inc, Medical Devices Deals, 2011 to YTD 2017 9

AveXis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

AveXis Raises USD65 Million in Venture Financing 11

AveXis Raises USD10 Million in Series C Financing Round 12

AveXis Enters into Licensing Agreement with Regenxbio 13

AveXis Amends Licensing Agreement with Nationwide Children's Hospital 15

Asklepios BioPharma Enters into Licensing Agreement with AveXis 15

ReGenX Biosciences Enters Into Licensing Agreement With AveXis 16

AveXis Raises USD287.8 Million in Public Offering of Shares 17

AveXis Prices Public Offering of Shares for USD146.6 Million 19

AveXis Completes Underwriter's Exercise of Over-Allotment Option of IPO 20

AveXis Raises USD2 Million in Private Placement of Shares and Warrants 21

AveXis Raises USD0.5 Million in Private Placement of 8% Notes 22

AveXis Inc, Key Competitors 23

AveXis Inc, Key Employees 24

AveXis Inc, Subsidiaries 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AveXis Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com